82
Views
3
CrossRef citations to date
0
Altmetric
Letters to the Editor

Activity of cetuximab as single agent in a patient with relapsed multiple myeloma

, , , , , & show all
Pages 562-564 | Received 13 Dec 2009, Accepted 22 Dec 2009, Published online: 25 Jan 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Flora Zagouri, Evangelos Terpos, Efstathios Kastritis & Meletios A. Dimopoulos. (2016) Emerging antibodies for the treatment of multiple myeloma. Expert Opinion on Emerging Drugs 21:2, pages 225-237.
Read now
Bastian von Tresckow, Boris Boell, Dennis Eichenauer, Denissa Beschorner, Stefan Knop, Maria-Elisabeth Goebeler, Jens Marcus Chemnitz, Michael Hallek, Andreas Engert & Kai Huebel. (2014) Anti-epidermal growth factor receptor antibody cetuximab in refractory or relapsed multiple myeloma: a phase II prospective clinical trial. Leukemia & Lymphoma 55:3, pages 695-697.
Read now

Articles from other publishers (1)

Alessandro Allegra, Giuseppa Penna, Andrea Alonci, Sabina Russo, Bruna Greve, Vanessa Innao, Viviana Minardi & Caterina Musolino. (2013) Monoclonal antibodies: potential new therapeutic treatment against multiple myeloma. European Journal of Haematology 90:6, pages 441-468.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.